Stay updated with breaking news from Open Label Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
![GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease - Vimarsana News](https://vimarsana.com/images/vimarsana-bigimage.jpg)
Phase III clinical trial of [18F]flurpiridaz PET diagnostic radiopharmaceutical meets co-primary endpoints for detecting Coronary Artery Disease (CAD) Trial also met its first key secondary
-- Approval based on MIRROR randomized controlled trial, which showed significant improvement and sustained patient response to KRYSTEXXA with methotrexate compared to KRYSTEXXA alone -- -- Trial
Investegate announcements from Redx Pharma plc, Redx Presents Poster on RXC004 at ASCO
/PRNewswire/ -- Bridge Biotherapeutics Inc. (KQ288330), a South Korean clinical-stage biotechnology company focused on developing novel drugs for cancer,...
GOTHENBURG, SE / ACCESSWIRE / April 27, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)XVIVO proudly announces the filing of an Investigational Device Exemption (IDE) application to the US Food